XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2026
Jan. 31, 2025
Income Statement [Abstract]        
Net sales $ 69,399 $ 67,167 $ 210,599 $ 163,324
Cost of products sold 50,854 48,788 151,404 118,505
Gross profit 18,545 18,379 59,195 44,819
Operating expenses 15,963 16,129 47,696 35,560
Operating profit 2,582 2,250 11,499 9,259
Other income, net 134 162 709 428
Interest expense (1,112) (1,137) (3,231) (2,051)
Profit before income taxes 1,604 1,275 8,977 7,636
Income tax expense (benefit) 528 (108) 2,204 1,000
Net earnings 1,076 1,383 6,773 6,636
Less: Net earnings attributable to the non-controlling interest 384 29 543 81
Net earnings attributable to Kewaunee Scientific Corporation $ 692 $ 1,354 $ 6,230 $ 6,555
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ 0.24 $ 0.47 $ 2.18 $ 2.29
Diluted (in dollars per share) $ 0.23 $ 0.45 $ 2.09 $ 2.20
Weighted average number of common shares outstanding        
Basic (in shares) 2,866 2,872 2,861 2,864
Diluted (in shares) 2,983 2,995 2,979 2,979